BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32737855)

  • 21. Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells.
    Lambertini E; Lolli A; Vezzali F; Penolazzi L; Gambari R; Piva R
    BMC Cancer; 2012 Oct; 12():445. PubMed ID: 23031797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Slug/Pcad pathway controls epithelial cell dynamics in mammary gland and breast carcinoma.
    Idoux-Gillet Y; Nassour M; Lakis E; Bonini F; Theillet C; Du Manoir S; Savagner P
    Oncogene; 2018 Feb; 37(5):578-588. PubMed ID: 28991231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Akt phosphorylates and activates HSF-1 independent of heat shock, leading to Slug overexpression and epithelial-mesenchymal transition (EMT) of HER2-overexpressing breast cancer cells.
    Carpenter RL; Paw I; Dewhirst MW; Lo HW
    Oncogene; 2015 Jan; 34(5):546-57. PubMed ID: 24469056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer.
    Dhasarathy A; Phadke D; Mav D; Shah RR; Wade PA
    PLoS One; 2011; 6(10):e26514. PubMed ID: 22028892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MIER3 induces epithelial-mesenchymal transition and promotes breast cancer cell aggressiveness via forming a co-repressor complex with HDAC1/HDAC2/Snail.
    Huang W; Chen J; Liu X; Liu X; Duan S; Chen L; Liu X; Lan J; Zou Y; Guo D; Zhou J
    Exp Cell Res; 2021 Sep; 406(1):112722. PubMed ID: 34242623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncofetal H19 RNA promotes tumor metastasis.
    Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
    Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smoking induces epithelial-to-mesenchymal transition in non-small cell lung cancer through HDAC-mediated downregulation of E-cadherin.
    Nagathihalli NS; Massion PP; Gonzalez AL; Lu P; Datta PK
    Mol Cancer Ther; 2012 Nov; 11(11):2362-72. PubMed ID: 22933707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.
    Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA
    Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
    Shah P; Gau Y; Sabnis G
    Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.
    Tsubaki M; Komai M; Fujimoto S; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
    J Exp Clin Cancer Res; 2013 Sep; 32(1):62. PubMed ID: 24011086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluid flow exposure promotes epithelial-to-mesenchymal transition and adhesion of breast cancer cells to endothelial cells.
    Fuh KF; Shepherd RD; Withell JS; Kooistra BK; Rinker KD
    Breast Cancer Res; 2021 Oct; 23(1):97. PubMed ID: 34641959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2.
    Ouchida AT; Kacal M; Zheng A; Ambroise G; Zhang B; Norberg E; Vakifahmetoglu-Norberg H
    Biochem Biophys Res Commun; 2018 Aug; 502(4):429-434. PubMed ID: 29803676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells.
    Yao Z; Zheng X; Lu S; He Z; Miao Y; Huang H; Chu X; Cai C; Zou F
    Breast Cancer; 2019 Nov; 26(6):835-845. PubMed ID: 31264076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].
    Rahimian A; Barati G; Mehrandish R; Mellati AA
    Mol Biol (Mosk); 2018; 52(3):474-481. PubMed ID: 29989579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2.
    Zhang N; Zhang H; Liu Y; Su P; Zhang J; Wang X; Sun M; Chen B; Zhao W; Wang L; Wang H; Moran MS; Haffty BG; Yang Q
    Cell Death Differ; 2019 May; 26(5):843-859. PubMed ID: 29988076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IMP3 expression is associated with epithelial-mesenchymal transition in breast cancer.
    Su P; Hu J; Zhang H; Li W; Jia M; Zhang X; Wu X; Cheng H; Xiang L; Zhou G
    Int J Clin Exp Pathol; 2014; 7(6):3008-17. PubMed ID: 25031719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRIM21 mediates ubiquitination of Snail and modulates epithelial to mesenchymal transition in breast cancer cells.
    Jin Y; Zhang Y; Li B; Zhang J; Dong Z; Hu X; Wan Y
    Int J Biol Macromol; 2019 Mar; 124():846-853. PubMed ID: 30502437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BTBD7 silencing inhibited epithelial- mesenchymal transition (EMT) via regulating Slug expression in human salivary adenoid cystic carcinoma.
    Yang L; Wang T; Zhang J; Wang X
    Cancer Biomark; 2017 Dec; 20(4):461-468. PubMed ID: 28946551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.
    Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R
    J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.